|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Rani Therapeutics Holdings, Inc. (RANI) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
19,710,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Rani Therapeutics Holdings is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. Co. has developed the RaniPill capsule, which is its novel, proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The RaniPill capsule is an orally ingestible pill approximately the size of a “000” capsule (or similar to the size of a standard fish oil or calcium pill) that is designed to automatically administer a precise therapeutic dose of medication upon deployment in the small intestine.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
5,356,165 |
5,789,530 |
Total Buy Value |
$0 |
$0 |
$10,772,992 |
$13,609,477 |
Total People Bought |
0 |
0 |
4 |
6 |
Total Buy Transactions |
0 |
0 |
7 |
75 |
Total Shares Sold |
0 |
0 |
5,265,165 |
5,265,165 |
Total Sell Value |
$0 |
$0 |
$10,582,982 |
$10,582,982 |
Total People Sold |
0 |
0 |
1 |
1 |
Total Sell Transactions |
0 |
0 |
1 |
1 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
South Lake One, Llc |
10% Owner |
|
2022-11-21 |
4 |
B |
$7.87 |
$25,195 |
I/I |
3,200 |
6,545,856 |
1.5 |
- |
|
South Lake One, Llc |
10% Owner |
|
2022-11-18 |
4 |
B |
$7.49 |
$99,657 |
I/I |
13,300 |
6,542,656 |
1.5 |
- |
|
Aequanimitas Limited Partnership |
10% Owner |
|
2022-11-03 |
4 |
B |
$6.90 |
$104,794 |
I/I |
15,192 |
5,262,978 |
1.5 |
- |
|
Aequanimitas Limited Partnership |
10% Owner |
|
2022-11-02 |
4/A |
B |
$6.31 |
$158,955 |
I/I |
25,197 |
5,247,786 |
1.5 |
- |
|
Quiroga Cortes Isidoro Alfonso |
10% Owner |
|
2022-11-02 |
4 |
B |
$6.31 |
$158,955 |
I/I |
25,197 |
5,247,786 |
1.5 |
- |
|
Aequanimitas Limited Partnership |
10% Owner |
|
2022-11-01 |
4/A |
B |
$5.98 |
$22,533 |
I/I |
3,768 |
5,222,589 |
1.5 |
- |
|
Quiroga Cortes Isidoro Alfonso |
10% Owner |
|
2022-11-01 |
4 |
B |
$5.98 |
$22,533 |
I/I |
3,768 |
5,222,589 |
1.5 |
- |
|
Aequanimitas Limited Partnership |
10% Owner |
|
2022-10-31 |
4/A |
B |
$6.11 |
$100,977 |
I/I |
16,523 |
5,218,821 |
1.5 |
- |
|
Quiroga Cortes Isidoro Alfonso |
10% Owner |
|
2022-10-31 |
4 |
B |
$6.11 |
$100,977 |
I/I |
16,523 |
5,218,821 |
1.5 |
- |
|
Sanford Svai S |
Chief Financial Officer |
|
2022-09-09 |
4 |
D |
$9.89 |
$181,600 |
D/D |
(18,362) |
120,738 |
|
- |
|
Hashim Mir |
Chief Scientific Officer |
|
2022-09-09 |
4 |
D |
$9.89 |
$201,103 |
D/D |
(20,334) |
138,466 |
|
- |
|
Imran Mir A |
Director |
|
2022-08-23 |
4 |
A |
$0.00 |
$0 |
I/I |
7,694 |
74,139 |
|
- |
|
Imran Mir A |
Director |
|
2022-08-23 |
4 |
A |
$0.00 |
$0 |
I/I |
7,694 |
22,660,053 |
|
- |
|
Farquharson Andrew |
Director |
|
2022-08-23 |
4 |
A |
$0.00 |
$0 |
I/I |
7,694 |
72,818 |
|
- |
|
Farquharson Andrew |
Director |
|
2022-08-23 |
4 |
A |
$0.00 |
$0 |
I/I |
7,694 |
248,929 |
|
- |
|
Imran Mir A |
Director |
|
2022-08-17 |
4 |
S |
$10.51 |
$853,672 |
I/I |
(80,252) |
66,445 |
|
- |
|
Farquharson Andrew |
Director |
|
2022-08-17 |
4 |
S |
$10.51 |
$853,672 |
I/I |
(80,252) |
65,124 |
|
- |
|
Imran Talat |
Chief Executive Officer |
|
2022-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
86,600 |
98,943 |
|
- |
|
Groen Eric |
General Counsel |
|
2022-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
24,500 |
24,500 |
|
- |
|
Sanford Svai S |
Chief Financial Officer |
|
2022-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
32,900 |
139,100 |
|
- |
|
Hashim Mir |
Chief Scientific Officer |
|
2022-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
41,200 |
158,800 |
|
- |
|
Farquharson Andrew |
Director |
|
2022-03-07 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,229,238) |
146,379 |
|
- |
|
Farquharson Andrew |
Director |
|
2022-03-07 |
4 |
A |
$0.00 |
$0 |
I/I |
2,309,490 |
2,375,617 |
|
- |
|
Farquharson Andrew |
Director |
|
2022-03-07 |
4 |
A |
$0.00 |
$0 |
I/I |
2,309,490 |
256,623 |
|
- |
|
Imran Mir A |
Director |
|
2022-03-07 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,229,238) |
147,959 |
|
- |
|
124 Records found
|
|
Page 4 of 5 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|